Clinical Trials Directory

Trials / Completed

CompletedNCT04484298

Dynamic Variation of Impedance Cardiography(DYVIC) as a Diagnostic Tool of Acute Heart Failure (AHF)

Dynamic Variation of Impedance Cardiography (ICG) a Diagnostic Tool of Acute Heart Failure (AHF) in Emergency Department (ED) Patients Admitted for Acute Dyspnea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Monastir · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

the study aimed to evaluate the diagnostic performance of cardiac output (CO) change after the use of trinitrine in the diagnosis of heart failure patients with acute dyspnea.

Detailed description

Acute heart failure (AHF) is a frequent condition in emergency department and is responsible of high number of admissions, complications, and deaths. despite advances in diagnostic techniques, AHF diagnosis still be challenging . Measurement of cardiac output (CO) is used to evaluate global cardiac function and changes in CO may be used to identify a change in the hemodynamic status of patient. the gold standard of measuring CO is thermodilution catheterization, however it is an invasive technique with high risks. Impedance cardiography (ICG) is a noninvasive method for measuring CO. it is performed by applying small electrical current to the chest through electrodes placed on the neck and sides. the pulsatile flow of blood causes fluctuations in the current, and the device calculates CO from the impedance waveform. In practice, the investigators connect the device "BIOPAC" by using four electrodes which the investigators place on the base of the neck (posterior face) and on the base of the thorax (posterior face). The ECG recording is taken simultaneously with two other electrodes placed at the right upper limb and left lower limb. In addition to detecting the electric current and the ECG, heart sounds are recorded using a sensor that is placed at the mitral site. Each patient is initially placed in a semi-sitting position at 30° for 5 minutes and then CO is measured (baseline CO). NTG (0.6 mg) is then given to the patient sublingually and CO measurement was repeated. CO is calculated by averaging three measurements at one minute intervals at baseline and after NTG administration. DeltaCO was defined as the percent of change of baseline CO after NTG test.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTReference position patient is put in a 30 degree supine position during 5 minutesEach patient is initially placed in a semi-sitting position at 30° for 5 minutes and then CO is measured (baseline CO)
DIAGNOSTIC_TESTnitroglucerin0.6 mg of Nitroglycerin was administered by sublingual root and CO was evaluated.

Timeline

Start date
2019-01-02
Primary completion
2020-02-29
Completion
2020-03-01
First posted
2020-07-23
Last updated
2021-03-29

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT04484298. Inclusion in this directory is not an endorsement.